Bone Biologics Stock Price, News & Analysis
Company Description
Bone Biologics (NASDAQ: bblgw) is a publicly traded company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies sector.
bblgw stock has gained 24.3% over the past year. Shares last traded at $21.00.
On a trailing twelve-month basis, Bone Biologics reported net income of -$3.1M and diluted earnings per share of $-2.65.
This page provides a comprehensive overview of bblgw stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bone Biologics (bblgw) stock last traded at $21.00. Over the past 12 months, the stock has gained 24.3%.
Latest News
Bone Biologics has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include conferences, offering, stock split, management. View all bblgw news →
SEC Filings
Bone Biologics has filed 5 recent SEC filings, including 2 Form 4, 1 Form 8-K, 1 Form 424B5, 1 Form 10-K. The most recent filing was submitted on March 13, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all bblgw SEC filings →
Financial Highlights
operating income reached -$3.2M, and net income was -$3.1M. Diluted earnings per share stood at $-2.65. The company generated -$2.7M in operating cash flow. With a current ratio of 13.85, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Bone Biologics (bblgw) currently stands at 362 shares, down 73.5% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 262%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Bone Biologics (bblgw) currently stands at 1.0 days, down 89.5% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 74% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
bblgw Company Profile & Sector Positioning
Bone Biologics (bblgw) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies sector and is listed on the NASDAQ.
Investors comparing bblgw often look at related companies in the same sector, including HeartSciences Inc (HSCSW), AINOS INC (AIMDW), Inspira Tech (IINNW), Spectral AI Inc (MDAIW), and Nexalin Tech (NXLIW). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate bblgw's relative position within its industry.